These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8894639)

  • 21. Impact of prenatal screening on the birth status of fetuses with Down syndrome at an urban hospital, 1972-1994.
    Caruso TM; Westgate MN; Holmes LB
    Genet Med; 1998; 1(1):22-8. PubMed ID: 11261425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent trends in the birth prevalence of Down syndrome in China: impact of prenatal diagnosis and subsequent terminations.
    Deng C; Yi L; Mu Y; Zhu J; Qin Y; Fan X; Wang Y; Li Q; Dai L
    Prenat Diagn; 2015 Apr; 35(4):311-8. PubMed ID: 25315427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
    Crossley JA; Aitken DA; Berry E; Connor JM
    J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down syndrome prevention program in a population with an older maternal age.
    Shohat M; Legum C; Romem Y; Borochowitz Z; Bach G; Goldman B
    Obstet Gynecol; 1995 Mar; 85(3):368-73. PubMed ID: 7862374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Birth prevalence of Down syndrome in Singapore from 1993 to 1998.
    Lai FM; Woo BH; Tan KH; Huang J; Lee ST; Yan TB; Tan BH; Chew SK; Yeo GS
    Singapore Med J; 2002 Feb; 43(2):070-6. PubMed ID: 11993893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A population-based study of prevalence of Down syndrome in Southern Thailand.
    Jaruratanasirikul S; Kor-Anantakul O; Chowvichian M; Limpitikul W; Dissaneevate P; Intharasangkanawin N; Sattapanyo A; Pathompanitrat S; Sriplung H
    World J Pediatr; 2017 Feb; 13(1):63-69. PubMed ID: 27878784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcome in Sweden after the Chernobyl accident.
    Ericson A; Källén B
    Environ Res; 1994 Nov; 67(2):149-59. PubMed ID: 7982390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: a proposed revised rate schedule for use in genetic and prenatal screening.
    Hecht CA; Hook EB
    Am J Med Genet; 1996 Apr; 62(4):376-85. PubMed ID: 8723068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down syndrome clusters in Germany after the Chernobyl accident.
    Burkart W; Grosche B; Schoetzau A
    Radiat Res; 1997 Mar; 147(3):321-8. PubMed ID: 9052678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of trisomy 21 in Germany before and after the Chernobyl accident.
    Sperling K; Pelz J; Wegner RD; Schulzke I; Struck E
    Biomed Pharmacother; 1991; 45(6):255-62. PubMed ID: 1832977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of prenatal diagnosis in Cuba: causes of low prevalence of Down syndrome.
    Méndez-Rosado LA; Hechavarría-Estenoz D; de la Torre ME; Pimentel-Benitez H; Hernández-Gil J; Perez B; Barrios-Martínez A; Morales-Rodriguez E; Soriano-Torres M; Garcia M; Suarez-Mayedo U; Cedeño-Aparicio N; Blanco I; Díaz-Véliz P; Vidal-Hernández B; Mitjans-Torres M; Miñoso S; Alvarez-Espinosa D; Reyes-Hernández E; Angulo-Cebada E; Torres-Palacios M; Lozano-Lezcano L; Lima-Rodriguez U; Mayeta M; Noblet M; Benítez Y; Lardoeyt-Ferrer R; Yosela-Martin S; Carbonell P; Pérez-Ramos M; de León N; Perez M; Carbonell J
    Prenat Diagn; 2014 Nov; 34(11):1049-54. PubMed ID: 24861354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Has prenatal screening influenced the prevalence of comorbidities associated with Down syndrome and subsequent survival rates?
    Halliday J; Collins V; Riley M; Youssef D; Muggli E
    Pediatrics; 2009 Jan; 123(1):256-61. PubMed ID: 19117890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of maternal age distribution and prenatal diagnosis on the population rates of Down syndrome--a comparative study of nineteen populations.
    Källén B; Knudsen LB
    Hereditas; 1989; 110(1):55-60. PubMed ID: 2528524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent trends in the prevalence of Down syndrome in Japan, 1980-1997.
    Hoshi N; Hattori R; Hanatani K; Okuyama K; Yamada H; Kishida T; Yamada T; Sagawa T; Sumiyoshi Y; Fujimoto S
    Am J Med Genet; 1999 Jun; 84(4):340-5. PubMed ID: 10340648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevalence of selected congenital anomalies in the Czech Republic: renal and cardiac anomalies and congenital chromosomal aberrations].
    Šípek A; Gregor V; Horáček J; Šípek A; Langhammer P
    Epidemiol Mikrobiol Imunol; 2013 Sep; 62(3):112-28. PubMed ID: 24116699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimates of live birth prevalence of children with Down syndrome in the period 1991-2015 in the Netherlands.
    de Graaf G; Engelen JJM; Gijsbers ACJ; Hochstenbach R; Hoffer MJV; Kooper AJA; Sikkema-Raddatz B; Srebniak MI; van der Kevie-Kersemaekers AMF; van Zutven LJCM; Voorhoeve E
    J Intellect Disabil Res; 2017 May; 61(5):461-470. PubMed ID: 28261902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of prenatal screening on the prevalence of Down syndrome in Slovenia.
    Rudolf G; Tul N; Verdenik I; Volk M; Brezigar A; Kokalj Vokač N; Jeršin N; Prosenc B; Premru Sršen T; Peterlin B
    PLoS One; 2017; 12(6):e0180348. PubMed ID: 28665986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.